Literature DB >> 21984738

Maternal cytomegalovirus-specific immune responses and symptomatic postnatal cytomegalovirus transmission in very low-birth-weight preterm infants.

Elizabeth P Ehlinger1, Emily M Webster, Helen H Kang, Aislyn Cangialose, Adam C Simmons, Kimberly H Barbas, Sandra K Burchett, Mary L Gregory, Karen M Puopolo, Karen P Puopolo, Sallie R Permar.   

Abstract

INTRODUCTION: Transmission of cytomegalovirus (CMV) via breast milk can lead to severe acute illness in very low-birth-weight (VLBW) preterm infants. Although the majority of CMV-seropositive women shed CMV in milk, symptomatic postnatal infection of VLBW infants occurs infrequently, suggesting that virologic or immunologic factors in milk may be associated with the risk and severity of postnatal CMV infection.
METHODS: We investigated the magnitude of CMV-specific cellular and humoral immune responses in milk of 30 seropositive mothers of VLWB preterm infants and assessed their relationship to milk CMV load and symptomatic CMV transmission.
RESULTS: Milk immunoglobulin G (IgG) avidity was inversely correlated to milk CMV load (r = -0.47; P = .009). However, milk CMV load and CMV-specific cellular and humoral immune responses were similar in mothers of VLBW infants with and those without symptomatic postnatal CMV infection.
CONCLUSIONS: Similar immunologic parameters in milk of CMV-seropositive mothers of VLBW infants with and without symptomatic postnatal CMV infection indicate that screening milk by these parameters may not predict disease risk. However, the inverse correlation between milk CMV IgG avidity and CMV load may suggest that enhancement of maternal CMV-specific IgG responses could aid in reduction of CMV shedding into breast milk.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21984738      PMCID: PMC3203229          DOI: 10.1093/infdis/jir632

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  48 in total

1.  Validation of an in-house assay for cytomegalovirus immunoglobulin G (CMV IgG) avidity and relationship of avidity to CMV IgM levels.

Authors:  Harry E Prince; Amy L Leber
Journal:  Clin Diagn Lab Immunol       Date:  2002-07

2.  Cytomegalovirus infection of extremely low-birth weight infants via breast milk.

Authors:  J Maschmann; K Hamprecht; K Dietz; G Jahn; C P Speer
Journal:  Clin Infect Dis       Date:  2001-11-12       Impact factor: 9.079

3.  Cytomegalovirus urinary excretion and long term outcome in children with congenital cytomegalovirus infection. Congenital CMV Longitudinal Study Group.

Authors:  D E Noyola; G J Demmler; W D Williamson; C Griesser; S Sellers; A Llorente; T Littman; S Williams; L Jarrett; M D Yow
Journal:  Pediatr Infect Dis J       Date:  2000-06       Impact factor: 2.129

4.  Epidemiology of transmission of cytomegalovirus from mother to preterm infant by breastfeeding.

Authors:  K Hamprecht; J Maschmann; M Vochem; K Dietz; C P Speer; G Jahn
Journal:  Lancet       Date:  2001-02-17       Impact factor: 79.321

5.  Tetramer-based quantification of cytomegalovirus (CMV)-specific CD8+ T lymphocytes in T-cell-depleted stem cell grafts and after transplantation may identify patients at risk for progressive CMV infection.

Authors:  J W Gratama; J W van Esser; C H Lamers; C Tournay; B Löwenberg; R L Bolhuis; J J Cornelissen
Journal:  Blood       Date:  2001-09-01       Impact factor: 22.113

6.  Transmission of cytomegalovirus via breast milk in extremely premature infants.

Authors:  S Hayashi; H Kimura; M Oshiro; Y Kato; A Yasuda; C Suzuki; Y Watanabe; T Morishima; M Hayakawa
Journal:  J Perinatol       Date:  2010-12-16       Impact factor: 2.521

7.  Secretory anti-human immunodeficiency virus (HIV) antibodies in colostrum and breast milk are not a major determinant of the protection of early postnatal transmission of HIV.

Authors:  P Becquart; H Hocini; M Lévy; A Sépou; M D Kazatchkine; L Bélec
Journal:  J Infect Dis       Date:  2000-02       Impact factor: 5.226

8.  Subclinical mastitis as a risk factor for mother-infant HIV transmission.

Authors:  J F Willumsen; S M Filteau; A Coutsoudis; K E Uebel; M L Newell; A M Tomkins
Journal:  Adv Exp Med Biol       Date:  2000       Impact factor: 2.622

9.  Evaluation of cytomegalovirus infections transmitted via breast milk in preterm infants with a real-time polymerase chain reaction assay.

Authors:  Ayako Yasuda; Hiroshi Kimura; Masahiro Hayakawa; Makoto Ohshiro; Yuichi Kato; Onrai Matsuura; Chizuko Suzuki; Tsuneo Morishima
Journal:  Pediatrics       Date:  2003-06       Impact factor: 7.124

10.  Subclinical mastitis among HIV-infected and uninfected Zimbabwean women participating in a multimicronutrient supplementation trial.

Authors:  Exnevia Gomo; Suzanne M Filteau; Andrew M Tomkins; Patricia Ndhlovu; Kim Fleischer Michaelsen; Henrik Friis
Journal:  Trans R Soc Trop Med Hyg       Date:  2003 Mar-Apr       Impact factor: 2.184

View more
  15 in total

1.  Intrahost Dynamics of Human Cytomegalovirus Variants Acquired by Seronegative Glycoprotein B Vaccinees.

Authors:  Ravit Arav-Boger; Sallie R Permar; Cody S Nelson; Diana Vera Cruz; Melody Su; Guanhua Xie; Nathan Vandergrift; Robert F Pass; Michael Forman; Marie Diener-West; Katia Koelle
Journal:  J Virol       Date:  2019-02-19       Impact factor: 5.103

2.  Humoral Immune Correlates for Prevention of Postnatal Cytomegalovirus Acquisition.

Authors:  Frances M Saccoccio; Jennifer A Jenks; Hannah L Itell; Shuk Hang Li; Madison Berry; Justin Pollara; Corey Casper; Soren Gantt; Sallie R Permar
Journal:  J Infect Dis       Date:  2019-07-31       Impact factor: 5.226

3.  Compartmentalized cytomegalovirus replication and transmission in the setting of maternal HIV-1 infection.

Authors:  Jennifer Slyker; Carey Farquhar; Claire Atkinson; Kristjana Ásbjörnsdóttir; Alison Roxby; Alison Drake; James Kiarie; Anna Wald; Michael Boeckh; Barbra Richardson; Katherine Odem-Davis; Grace John-Stewart; Vincent Emery
Journal:  Clin Infect Dis       Date:  2013-11-05       Impact factor: 9.079

4.  Breast Milk Human Cytomegalovirus (CMV) Viral Load and the Establishment of Breast Milk CMV-pp65-Specific CD8 T Cells in Human CMV Infected Mothers.

Authors:  David C Moylan; Sunil K Pati; Shannon A Ross; Karen B Fowler; Suresh B Boppana; Steffanie Sabbaj
Journal:  J Infect Dis       Date:  2017-11-27       Impact factor: 5.226

Review 5.  Impact of breast milk-acquired cytomegalovirus infection in premature infants: Pathogenesis, prevention, and clinical consequences?

Authors:  Erin A Osterholm; Mark R Schleiss
Journal:  Rev Med Virol       Date:  2020-07-13       Impact factor: 11.043

6.  Cross-sectional study of cytomegalovirus shedding and immunological markers among seropositive children and their mothers.

Authors:  Jennifer D Stowell; Karen Mask; Minal Amin; Rebekah Clark; Denise Levis; Will Hendley; Tatiana M Lanzieri; Sheila C Dollard; Michael J Cannon
Journal:  BMC Infect Dis       Date:  2014-11-12       Impact factor: 3.090

Review 7.  Immunity to cytomegalovirus in early life.

Authors:  Ariane Huygens; Nicolas Dauby; David Vermijlen; Arnaud Marchant
Journal:  Front Immunol       Date:  2014-10-30       Impact factor: 7.561

Review 8.  The impact of differential antiviral immunity in children and adults.

Authors:  Andrew J Prendergast; Paul Klenerman; Philip J R Goulder
Journal:  Nat Rev Immunol       Date:  2012-09       Impact factor: 53.106

9.  Postnatal cytomegalovirus exposure in infants of antiretroviral-treated and untreated HIV-infected mothers.

Authors:  Sarah A Meyer; Daniel J Westreich; Emily Patel; Elizabeth P Ehlinger; Linda Kalilani; Rachel V Lovingood; Thomas N Denny; Geeta K Swamy; Sallie R Permar
Journal:  Infect Dis Obstet Gynecol       Date:  2014-03-03

10.  Breast Milk Prefusion F Immunoglobulin G as a Correlate of Protection Against Respiratory Syncytial Virus Acute Respiratory Illness.

Authors:  Natalie I Mazur; Nicole M Horsley; Janet A Englund; Maaike Nederend; Amalia Magaret; Azad Kumar; Shamir R Jacobino; Cornelis A M de Haan; Subarna K Khatry; Steven C LeClerq; Mark C Steinhoff; James M Tielsch; Joanne Katz; Barney S Graham; Louis J Bont; Jeanette H W Leusen; Helen Y Chu
Journal:  J Infect Dis       Date:  2019-01-01       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.